1.Development on neurodegenerative disorder modeling with induced pluripotent stem cells
Chinese Pharmacological Bulletin 2014;(9):1185-1188,1189
Remarkable advances in cellular reprogramming have made it possible to investigate relevant cell populations derived from induced pluripotent stem cells ( iPSCs ) of patients. Be-cause many diseases have its specific genetic information, using the cells to convert into iPSCs can build up a set of genetic pro-file of diseases. The iPSCs which contain the genetic contribution of the donor can be expanded and differentiated into cells of the affected lineages to show aberrant phenotypes in culture. To date, over fifty such disease models have been reported, and while the field is young and hurdles remain, we can foresee the huge potential of it in drug screening. Recent studies using iP-SCs to model various neurogenetic disorders are summarized. Compared to the traditional methods, we analyze the future de-velopment of iPSC based disease models and its past application on high-throughput screening ( HTS) and high-content screening ( HCS) .
2.Establishment and evaluation of intravascular thrombosis used for cerebral embolism model
Chinese Pharmacological Bulletin 2015;(11):1620-1622,1623
Aim To produce cerebral embolism rat model via in-travascularly formed thrombus. Methods Thrombus was formed in common carotid artery ( CCA ) by constant galvanic stimulation, then it was shattered and MCA was occluded. To i-dentify the feature of the model, focal cerebral blood flow ( CBF ) , cerebral infarction volume and behavior tests were measured. Thrombolysis with tissue plasminogen activator ( tPA) were observed. Results This model developed a reduction of blood flow (30% of baselines) within the MCA territory. Signifi-cant infarction and neurological disorder were observed 24 h after the embolism onset. Thrombolysis with tPA ameliorated the path-ological process which was mentioned above. Conclusion Cer-ebral embolism model induced by intravascular formed thrombus in rat is suitable for the research of pathology and thrombolytics for embolic stroke.
3.A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients
Jianxin MA ; Hongzhou LU ; Jiangrong WANG ; Renfang ZHANG ; Yufang ZHENG ; Li LIU ; Tangkai QI ; Yinzhong SHEN
Chinese Journal of Internal Medicine 2008;47(7):574-577
Objectives Occult HBV infection is defined by positive HBV DNA in individuals with undetectable levels of HBsAg.The objective of this study was to assess the prevalence of occult HBV infection in HIV-infected patients.Methods Serum samples were obtained from 105 HBs Ag-negative HIV patients who were hospitalized and were not giyen anti-virus treatment at Shanghai Public Health Clinical Center.Microparticle enzyme immunoassay(MEIA)was used to detect HBV serologic markers(HBsAg,anti-HBs,HBeAg,anti-Hbe and anti-HBc).EUSA was used to detect HCV antibody.CD4+ T cell count was examined with flow cytometry.Nested PCR was used to amplify surface protein region of HBV.Results 32(30.5%)patients(27 men,5 women)were HBV DNA positive in the 105 HBsAg-negative HIV-infected patients(92 men and 13 women).22 patients(including 5 patients with HBV DNA+)were in 16-30 years group,44 patients(including 15 patients with HBV DNA+)were in 31-49 years group and 39 patients(including 12 patients with HBV DNA+)were in 50-75 years group.5 patients were negative for all HBV serologic markers and 27 patients detected with at least one of anti-HBc.anti.Hbe or anti-HBs.14 patients (29.8%)with HBV DNA+in 47 HIV-infected patients were coinfected with HCV,18 patients(31.0%)were HBV DNA+in 58 HIV-monoinfected patients.The median absolute CD4+T eell count was 145.1cells/μ1(4-623 cells/μ1),26 patients(34.7%)were HBV DNA+in 75 AIDS patients with CD4+T cell<200 cells/μ1 and 6 patients(20.0%)HBV DNA+in 30 HIV-infected patients with CD4+ T cell>200cells/μ1.No statistical significant association could be established between the above factors.Conclusions It is found tIlatoccult HBV did occur in HIV-infected patients.No statistical significant association could be established between occult HBV infection and gender,age,HBV serologic markers,coinfected HCV and CD4+T cell count.
4.Application of 99TCm tracer technique in rabbit cerebral thromboembolic stroke
Chunhua HAO ; Xiangwei XU ; Yinzhong MA ; Rui ZHANG ; Shuangyong SUN ; Weiting WANG ; Zhuanyou ZHAO ; Lida TANG
Drug Evaluation Research 2017;40(5):648-651
Objective To study the application of 99Tcm in rabbit cerebral thromboembolic stroke and thrombolysis effect of recombinant tissue plasminogen activator (rt-PA).Methods The 0.5 mL radioactive pertechnetate sodium (specification:5 mCi/2mL and radiation intensity 92.5 MBq/mL) was combined with 30 μL stannous chloride (5 mg/mL),and the 20 μL mixture was joined to whole blood,red blood cells,and plasma for labelling.Then 50 μL CaCl2 (0.5 mol/L) and bovine thrombin (50 IU/mL) were doped in mixture,and rapidly sucked into a polyethylene plastic pipe (PE80).Thrombus was formed for 2 h at 37 ℃ and cut into small pieces of 10 mm.Autologous blood clots combined with 99Tcm from external carotid artery were injected to internal carotid artery of rabbit,the radioactivity (counts per minute,CPM) was measured by gamma counting instrument,and the improvement of rt-PA 4.5 mg/kg (clinical equivalent dose) on this model was observed.Results After thromboembolism,CPM increased approximately by (5.1 ± 1.3) times,which suggested that the model was reliable.The rt-PA 4.5 mg/kg had significant progressive thrombolysis effect.Conclusion 99Tcm tracer technology could be applied to rabbit cerebral stroke model,which is stable and reliable